SEC Form 5 · accession 0001388410-19-000012
PARALLAX HEALTH SCIENCES, INC. · PRLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorn Gorlach
10% Owner
Period of report
Dec 31, 2017
Accepted (ET)
Jan 28, 2019 · 2:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PREFERRED STOCK (SERIES B)F1 | $0.25 | Jan 23, 2017 | A | 30,000 | A | Jan 23, 2017 | Jan 23, 2019 | COMMON STOCK | 600,000 | 393,393 | I |
| WARRANTS (PREFERRED SERIES B) | $0.75 | Jan 23, 2017 | A | 15,000 | A | Jan 23, 2017 | Jan 23, 2019 | COMMON STOCK | 300,000 | 408,393 | I |
Explanation of responses
- F1Pursuant to Conversion Rights, holders of Series B Convertible Preferred Stock may elect to convert their shares at the then Conversion Ratio at any time in whole or in part for a period of two years from the date of purchase.